Treatment adherence Treatment adherence was assessed by calculating the proportion of days covered, defined as the number of days covered by the study drug (excluding the grace period) at 1 year after the date of filling the first prescription, divided by 365 days, for all patients who were alive at 1 year after drug initiation
Zheng X, Lin D, Zhang Y, Lin Y, Song J, Li S, Sun Y
Cagrilintide | GLP-1 (SG) Amylin Analog + GLP-1 Receptor Agonist Blend Blend Components: Cagrilintide CAS: 1415456-99-3 Formula: C 194 H 312 N 54 O 59 S 2 M.W.: 4425.1146 g/mol GLP-1 (SG) CAS: 910463-68-2 Formula: C 187 H 291 N 45 O 59 M.W.: 4113.5751 g/mol Purity: 99%+ HPLC Verified Ref No.:CGL-0002VI Ref No.:CGL-0005VI For Research Use Only (RUO) Not for human or veterinary use
tBid translocates to the mitochondria, triggering cytochrome c release and subsequent activation of caspase-9 and caspase-3
In order to regenerate, you need three things
1) Ensure that Part 1 and Part 2 are mixed properly before the injection